Fintel reports that Ra Capital Management, L.p. has filed a 13G/A form with the SEC disclosing ownership of 0 shares of Larimar Therapeutics Inc (LRMR), effectively closing their position.
Larimar Therapeutics, Inc., is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program in the U.S. as a potential treatment for FA.
Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.
What are other large shareholders doing?
Deerfield Management Company, L.p. (series C) holds 5,830,249 shares representing 13.47% ownership of the company. No change in the last quarter.
CHI Advisors LLC holds 3,415,148 shares representing 7.89% ownership of the company. In it’s prior filing, the firm reported owning 1,515,148 shares, representing an increase of 55.63%. The firm increased its portfolio allocation in LRMR by 159.05% over the last quarter.
Woodline Partners LP holds 1,941,739 shares representing 4.49% ownership of the company.
Mangrove Partners holds 1,292,812 shares representing 2.99% ownership of the company. In it’s prior filing, the firm reported owning 867,812 shares, representing an increase of 32.87%. The firm increased its portfolio allocation in LRMR by 187.70% over the last quarter.
What is the overall institutional sentiment?
There are 76 funds or institutions reporting positions in Larimar Therapeutics Inc. This is an increase of 2 owner(s) or 2.70%.
Average portfolio weight of all funds dedicated to Larimar Therapeutics Inc is 0.0688%, a decrease of 5.5000%. Total shares owned by institutions increased in the last three months by 8.05% to 16,715,329 shares.
This article originally appeared on Fintel
Are You Still Paying With a Debit Card?
The average American spends $17,274 on debit cards a year, and it’s a HUGE mistake. First, debit cards don’t have the same fraud protections as credit cards. Once your money is gone, it’s gone. But more importantly you can actually get something back from this spending every time you swipe.
Issuers are handing out wild bonuses right now. With some you can earn up to 5% back on every purchase. That’s like getting a 5% discount on everything you buy!
Our top pick is kind of hard to imagine. Not only does it pay up to 5% back, it also includes a $200 cash back reward in the first six months, a 0% intro APR, and…. $0 annual fee. It’s quite literally free money for any one that uses a card regularly. Click here to learn more!
Flywheel Publishing has partnered with CardRatings to provide coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.